8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 17, 2026·SEC
Material company update
Mar 30, 2026·SEC
OraSure Technologies, Inc.(OSUR)Earnings, Financials & Key Ratios
OSUR•NASDAQ
$4.32
Price updated Jul 7, 2026
AboutOraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.Show more
- Revenue$115M-38.1%
- EBITDA-$58M-495.5%
- Net Income-$69M-252.5%
- EPS (Diluted)-0.94-261.5%
- Gross Margin41.9%+2.2%
- EBITDA Margin-50.37%-862.1%
- Operating Margin-59.23%-434.3%
- Net Margin-59.76%-469.4%
- ROE-18.3%-294.6%
OSUR Price & Volume
OraSure Technologies, Inc. (OSUR) stock price & volume — 10-year historical chart
Loading chart...
OraSure Faces Severe Revenue Contraction and Liquidity
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and solvency crisis
Key Thesis Takeaways
- OraSure Technologies is currently navigating a critical transition period characterized by a 99.9% year-over-year revenue decline in 2026Q1 as pandemic-era demand evaporates.
- The company's inability to pivot its cost structure, evidenced by an operating margin of -83%, suggests significant operational headwinds that threaten long-term viability.
- Investors should monitor the rapid depletion of cash reserves, which fell to $177.0 million, as the firm struggles to achieve sustainable profitability in its core diagnostic segments.
Verdict Logic
the company's cash and equivalents have declined from $290.4 million in 2023Q4 to $177.0 million in 2026Q1, signaling an unsustainable burn rate that poses an imminent liquidity risk.
OSUR Growth Metrics
OraSure Technologies, Inc. (OSUR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-0.4%
5 Years-7.7%
3 Years-33.29%
TTM-47.34%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-64.96%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-148.39%
Return on Capital
10 Years2.37%
5 Years-2.5%
3 Years-2.75%
Last Year-16.83%
OSUR Recent Earnings
OraSure Technologies, Inc. (OSUR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.32-39.1%
$0.23
Rev
$28M+0.8%
$28M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.19-11.8%
$0.17
Rev
$27M+1.0%
$26M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.13+18.8%
$0.16
Rev
$27M+2.4%
$26M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.19-26.7%
$0.15
Rev
$31,242-8.0%
$33,969
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.32vs $0.23-39.1% | $28Mvs $28M+0.8% |
| Q1 2026 | Feb 25, 2026 | $0.19vs $0.17-11.8% | $27Mvs $26M+1.0% |
| Q4 2025 | Nov 5, 2025 | $0.13vs $0.16+18.8% | $27Mvs $26M+2.4% |
| Q3 2025 | Aug 5, 2025 | $0.19vs $0.15-26.7% | $31,242vs $33,969-8.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for OraSure Technologies, Inc. (OSUR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $4.32 | $310.89M | -4.60 | -38.1% | -59.76% | -18.3% | — | |
| $17.00 | $1.16B | -1.02 | -1.89% | -45.57% | -56.31% | — | |
| $570.25 | $45.29B | 43.60 | 10.42% | 24.63% | 70.87% | — | |
| $95.84 | $166.94B | 25.76 | 5.67% | 13.91% | 12.09% | — | |
| $156.30 | $56.63B | 26.81 | 8.23% | 5.33% | 4.54% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
Compare OSUR vs Peers
OraSure Technologies, Inc. (OSUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OSUR SEC Filings & Documents
OraSure Technologies, Inc. (OSUR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when OSUR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OSUR Frequently Asked Questions
OraSure Technologies, Inc. (OSUR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is OraSure Technologies, Inc.'s revenue?
OraSure Technologies, Inc. (OSUR) reported $85.1M in revenue for fiscal year 2025. This represents a 24% increase from $68.7M in 1996.
How fast is OraSure Technologies, Inc. growing?
OraSure Technologies, Inc. (OSUR) saw revenue decline by 38.1% over the past year.
Is OSUR profitable?
OraSure Technologies, Inc. (OSUR) reported a net loss of $52.7M for fiscal year 2025.
Dividend & Returns
What is OSUR's return on equity?
OraSure Technologies, Inc. (OSUR) has a return on equity (ROE) of -18.3%. Negative ROE indicates the company is unprofitable.
What is OraSure Technologies, Inc.'s free cash flow?
OraSure Technologies, Inc. (OSUR) had negative free cash flow of $47.9M in fiscal year 2025, likely due to heavy capital investments.